Verus Financial Partners, Inc. Abbott Laboratories Transaction History

Verus Financial Partners, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $15,013 - $17,671	155 Added 8.35%	2,012 $203,000
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $15,399 - $18,066	-162 Reduced 8.02%	1,857 $203,000
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $195,358 - $226,188	2,019 New	2,019 $212,000
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $327,390 - $356,761	-3,118 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $285,733 - $347,002	3,118 New	3,118 $339,000
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $208,692 - $226,287	-2,550 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $3,498 - $4,080	48 Added 1.92%	2,550 $214,000
Q1 2019 Apr 19, 2019	BUY	$66.22 - $80.06 $165,682 - $200,310	2,502 New	2,502 $200,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Verus Financial Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Verus Financial Partners, Inc. with notifications on news.